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The selectins and their ligands are required for
leukocyte extravasation during inflammation.
Several glycoproteins have been suggested to
bind to E-selectin in vitro, but the complete
identification of its physiological ligands has
remained elusive. Here, we showed that E-
selectin ligand-1 (ESL-1), P-selectin glycoprotein
ligand-1 (PSGL-1), and CD44 encompassed all
endothelial-selectin ligand activity on neutro-
phils by using gene- and RNA-targeted loss
of function. PSGL-1 played a major role in the
initial leukocyte capture, whereas ESL-1 was
critical for converting initial tethers into steady
slow rolling. CD44 controlled rolling velocity
and mediated E-selectin-dependent redistribu-
tion of PSGL-1 and L-selectin to a major pole on
slowly rolling leukocytes through p38 signaling.
These results suggest distinct and dynamic
contributions of these three glycoproteins in
selectin-mediated neutrophil adhesion and
signaling.
INTRODUCTION
The selectins, a family of three C-type lectins, mediate
interactions among leukocytes, platelets, and the endo-
thelium (Ley, 2003; McEver, 2002; Vestweber and Blanks,
1999). P-selectin (encoded by the Selp gene), stored in
platelets and endothelial cells, is rapidly expressed on
the cell surface upon stimulation and mediates most
leukocyte rolling in the first hour of an inflammatory chal-
lenge. L-selectin is constitutively expressed on the tip of
leukocyte microvilli and plays critical roles in the homing
of lymphocytes to lymph nodes. L-selectin may also
participate in leukocyte recruitment in systemic venules
through secondary tethers between circulating and
adherent leukocytes (Sperandio et al., 2003). E-selectin(encoded by the Sele gene) expression is restricted to
the endothelium, induced by inflammatory cytokines
such as TNF-a and IL-1, and mediates the slow leukocyte
rolling in inflamed venules. E-selectin plays a major role in
leukocyte recruitment to inflammatory sites through its
close collaboration with P-selectin (Bullard et al., 1996;
Frenette et al., 1996; Labow et al., 1994).
All three selectins bind to a(2,3)sialylated and a(1,3)
fucosylated carbohydrate structures similar to the sialyl
Lewis x (sLex) determinant. Although P-and L-selectins
additionally require sulfation of the polypeptide or carbo-
hydrate ligand, sLex appears to be sufficient for Ca2+-
dependent binding to E-selectin. Several studies have
indicated that the engagement of a selectin on its ligand
can trigger signaling inside the leukocyte, and this may
involve tyrosine phosphorylation and p38 mitogen-
activated protein kinase (MAPK) activation, thus resulting
in activation of the b2-integrins, and clustering of adhesion
molecules on the cell surface (Evangelista et al., 1999;
Green et al., 2004; Lo et al., 1991; Simon et al., 2000;
Smith et al., 2004). Genetic-deletion studies have revealed
that P-selectin glycoprotein-1 (PSGL-1; encoded by the
Selplg gene) was the major ligand for P-selectin (Xia
et al., 2002; Yang et al., 1999).
The binding requirements of E-selectin to highly con-
served, poorly immunogenic carbohydrates have ham-
pered efforts to generate inhibitory monoclonal antibodies
and the identification of physiological E-selectin ligands
(ESLs) (Vestweber and Blanks, 1999). Because most cells
can roll on E-selectin when transfected with a vector en-
coding an a(1,3)-fucosyltransferase gene that introduces
sLex to the cell surface, E-selectin may interact indiscrim-
inately with many glycoproteins and glycolipids.
Several glycostructures on various hematopoietic cells
have indeed been proposed to bind to E-selectin with
in vitro affinity-purification techniques, including PSGL-1
(Moore et al., 1994), ESL-1 (Steegmaier et al., 1995),
CD44 (Dimitroff et al., 2001), L-selectin (on human but
not mouse) (Picker et al., 1991; Zollner et al., 1997),
CD43 (Fuhlbrigge et al., 2006; Matsumoto et al., 2005),
b2 integrins (Kotovuori et al., 1993), glycolipids (AlonImmunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 477
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(Jones et al., 1997; Montoya et al., 1999). Of these,
PSGL-1hasclearly beenshown tocontribute toE-selectin-
mediated leukocyte rolling in vivo (Hirata et al., 2000; Xia
et al., 2002). However, leukocyte-rolling velocities, a trade-
mark function of ESLs (Kunkel and Ley, 1996), were not
altered in Selplg/ mice (Xia et al., 2002). In addition, the
fact that theoverall phenotypeofSelplg/mice resembles
that of Selp/ animals suggested that PSGL-1 predomi-
nantly functions asaP-selectin ligandand implied thepres-
enceof othermajorESLs.Our recent studieshave revealed
that CD44 is a physiological ESLmediating the slow leuko-
cyte rolling on E-selectin in vivo and that it collaborates
with PSGL-1 in neutrophil extravasation to inflamed sites
(Katayama et al., 2005). However, the alterations in leuko-
cyte behavior in mice lacking both CD44 and PSGL-1 are
notassevereas inmicedeficient inbothP-andE-selectins,
a finding supporting the existence of at least three physio-
logical ESLs or the compensation in gene-knockout mice
by other glycoprotein or glycolipid structures.
Among the aforementioned candidate ligands, ESL-1
was isolated by affinity-purification techniques from
myeloid cells (Steegmaier et al., 1995). ESL-1 protein
sequence is identical to a membrane sialoglycoprotein
of the medial cisternae of the rat Golgi complex (MG-
160 [Gonatas et al., 1989]) and the avian cysteine-rich
FGF receptor (CFR [Burrus et al., 1992]). These glycopro-
teins are now known to be encoded by a single gene locus
named Glg1 (Golgi-complex-localized glycoprotein-1).
Indeed, most ESL-1 is found in the Golgi apparatus,
whereas a relatively small fraction is expressed on the
cell surface where it has been immunolocalized to micro-
villi (Steegmaier et al., 1997). In myeloid cells, ESL-1 is
thought to be endowed with E-selectin-binding activity
notably through a(1,3) fucosylation (Huang et al., 2000).
In other cell systems, the protein may be secreted as
part of the TGF-b complex where it is bound through disul-
phide linkage to the latency-associated peptide of the
TGF-b1 precursor (Olofsson et al., 1997). It may also asso-
ciate intracellularly with several FGF family members (Kohl
et al., 2000). These studies suggest important functions of
ESL-1 outside the immune system.
Here, we have used short hairpin RNA (shRNA) interfer-
ence specific to Glg1, delivered by lentiviral transduction,
to knock down ESL-1 specifically in hematopoietic cells
deficient or sufficient in PSGL-1, CD44, or both. Our
results reveal that ESL-1 is themost versatile and powerful
ESL and that, together with PSGL-1 and CD44, they com-
prise all detectable ESL activity on neutrophils. Moreover,
we show here that these three glycoproteins exhibit
dynamic, specialized functions in selectin-dependent
leukocyte rolling, adhesion, and signaling.
RESULTS
Specific Knockdown of ESL-1 in the Hematopoietic
System
To knock down ESL-1 expression specifically in the
hematopoietic system, we generated independently two478 Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc.vectors encoding shRNA sequences specific to its intralu-
minal domain. The lentiviral vector separately expresses
the green fluorescent protein (GFP), allowing efficient de-
tection of transduced cells. After preliminary transduction
studies of myeloid (32D) and nonmyeloid (bEnd.3) cells,
we chose the most robust vector for all studies presented
herein (Figure S1 in the Supplemental Data online). Trans-
duction of 32D cells with this shESL-1 lentiviral vector pro-
foundly reduced (by 70%) ESL-1 mRNA expression as
detected by quantitative PCR (Figure 1A) and ESL-1 pro-
tein amounts (by 85%) in lysates of transduced cells
sorted on the basis of GFP expression (Figure 1B, upper
panel). Because most ESL-1 is expressed in the Golgi ap-
paratus, we biotinylated surface proteins to assess specif-
ically the effect of shESL-1 on ESL-1 expressed on the cell
membrane. We found that ESL-1 was virtually undetect-
able on the surface of shESL-1-transduced 32D cells
(Figure 1B, lower panel). Importantly, transduction with
a control vector did not alter ESL-1 protein amounts rela-
tive to untransduced cells (Figure 1B).
To assess the efficiency of shESL-1 knockdown in pri-
mary hematopoietic cells, we generated chimeric mice
by transplantation of hematopoietic stem and progenitor
cells. In these studies, we purified bone-marrow-derived
lineage-negative (Lin) cells from wild-type, Selplg/,
Cd44/, or Selplg/ Cd44/ mice. Lin cells were
then transduced with the shESL-1 or GFP control vectors
and transplanted into lethally irradiated wild-type recipient
mice. After a recovery of at least 3 weeks, the average fre-
quencies of mature GFP+ blood leukocytes descendant
from transduced progenitor cells ranged between 10%
and 25% of all circulating leukocytes in blood (Table S1).
ESL-1 downregulation did not have any major effect on
the survival or growth of hematopoietic cells because
the engraftment and percentages of circulating trans-
duced leukocytes were comparable to those of the control
group (Table S1). Immunostaining of shESL-1-transduced
blood leukocytes from transplanted animals revealed
a marked reduction in ESL-1 expression in the perinuclear
region corresponding to the Golgi apparatus (Figure 1C).
However, shESL-1 did not reduce the expression of other
known selectin ligands (PSGL-1 and CD44; Figure S2).
These results validate this knockdown strategy for study-
ing the function of surface ESL-1 in mature leukocytes.
ESL-1 Is a Major Physiological E-Selectin Ligand
that Collaborates with PSGL-1
To assess the contribution of ESL-1 in leukocyte binding
to E-selectin, we first analyzed the ability of transduced
neutrophils from transplanted mice to bind to soluble E-
selectin in a fluid-phase assay. In agreement with previous
reports (Katayama et al., 2005; Xia et al., 2002), Selplg/
neutrophils displayed a marked reduction in soluble E-
selectin-IgM chimera binding, which was further reduced
by 50% in Selplg/ Cd44/ neutrophils (Figure 2A).
Absence of either ESL-1 or CD44 reduced binding to E-
selectin by 30%, and E-selectin binding was modestly
reduced further by the combined deficiency of CD44
and ESL-1 (Figure 2A). Binding of soluble P-selectin, in
Immunity
Identification of Physiological E-Selection LigandsFigure 1. ESL-1 Knockdown in 32D Cells and Circulating Leukocytes
32D cells transduced with the control or shESL vectors were sorted on the basis of GFP expression.
(A) Q-PCR of RNA extracts from GFP+ cells. Data were normalized to the amounts of GAPDH.
(B) Immunoblot analyses of 32D cell lysates untransduced (Untrsd), transduced with the control (GFP) vectors, or transduced with shESL-1 vectors.
Percentages reflect the proportion ESL-1 protein detected in the shESL-1 groups relative to untransduced cells. Shown is one representative
experiment of three.
(C) Immunofluorescence staining of cytospin preparations of blood leukocytes frommice transplanted with BM cells untransduced, transduced with
GFP control vectors, or transduced with shESL-1 vectors. Representative neutrophils expressing GFP (green) are depicted. Nuclei are stained with
DAPI (blue), and ESL-1 is stained with a polyclonal antibody (red). The scale bar represents 10 mm.contrast, was not affected by the absence of ESL-1
(Figure S3). Strikingly, the ability of soluble E-selectin to
bind to shESL-1-transduced neutrophils deficient in
PSGL-1 was completely abrogated (Figures 2A and 2B),
suggesting a cooperation between these two glycopro-
teins for high-affinity binding.
To assess the contribution of ESL-1 in leukocyte rolling
in vivo, we examined cremasteric venules of TNF-a-
stimulated mice transplanted with transduced Lin cells
by using intravital microscopy. We tracked the behavior
of transduced (GFP+) leukocytes by using high-speed
widefield fluorescence microscopy (Figure S4 and Movie
S1). The rolling frequency of transduced leukocytes was
reduced by 75% in the absence of PSGL-1 but was
not affected by the absence of ESL-1 alone (Figure 2C).
ESL-1 knockdown in Cd44/ leukocytes resulted in a
marked increase in rolling frequencies, and this, interest-
ingly, is reminiscent of Sele/ mice (Kunkel and Ley,
1996). In contrast, rolling was dramatically reduced (by
93%) when both PSGL-1 and ESL-1 were absent from
the leukocyte surface (Figure 2C). Rolling frequencies
tended to be further reducedwhen CD44was also absent,
although this did not reach statistical significance in a
multigroup analysis of variance (Figure 2C). These results
indicate that PSGL-1 and ESL-1 are the major selectin
ligands mediating the initial leukocyte tethering and rolling
in vivo.
Differential Contributions of PSGL-1, ESL-1,
and CD44 in Leukocyte Rolling
E-selectin but not P-selectin controls slow leukocyte roll-
ing on inflamed venules, and this rolling may in turn serve
to promote an efficient transition to firm adhesion and tokeep extravasation localized to the inflamed area (Jung
et al., 1998; Kunkel and Ley, 1996; Ley et al., 1998). Al-
though Selplg/ leukocytes had rolling velocities similar
to those of wild-type animals (Figures 3A and 3B), leuko-
cytes deficient in CD44 or ESL-1 exhibited a significant in-
crease in rolling velocities (Figures 3A and 3B). In addition,
the rolling velocities of leukocytes deficient in ESL-1 and
either CD44 or PSGL-1 were further increased compared
to those with any single deficiency, suggesting that ESL-1
cooperates with CD44 and PSGL-1 in controlling rolling
velocities. Leukocyte velocities were further increased
when all three glycoproteins were absent (18 ± 4 mm/s),
to a level comparable to those observed in Sele/ mice
reconstituted with wild-type Lin cells transduced with
the control vector (18 ± 1 mm/s, n = 32 venules from
four mice). These results suggest that these three glyco-
proteins comprise most, if not all, ESLs on leukocytes
required to control the slow rolling mediated by E-selectin.
In addition to the changes in rolling velocities, shESL-1-
transduced leukocytes exhibited a characteristic ‘‘skip-
ping’’ behavior. Velocity tracings revealed cycles of short
steady rolling periods followed by release and retethering
further downstream, thus resulting in sharp and transient
increases in velocity (Figure 4A and Movies S2 and S3).
Consequently, leukocytes moving in this fashion failed to
engage in steady rolling. Rolling kinetics of ESL-1-
deficient cells sharply contrasted with the steady and
slow motion of wild-type or Selplg/ leukocytes and the
steady but faster rolling of Cd44/ leukocytes
(Figure 4A). Quantitation of this rolling behavior revealed
that approximately half of shESL-1-transduced leuko-
cytes displayed such rolling kinetics, compared to only
15% of wild-type or Cd44/ leukocytes (Figure 4B).Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 479
Immunity
Identification of Physiological E-Selection LigandsFigure 2. Contribution of ESL-1, PSGL-1,
and CD44 in Binding of Soluble E-Selec-
tin and in In Vivo Rolling-Flux Fractions
Flow-cytometric analyses of E-selectin-IgM
chimera binding to blood neutrophils obtained
from mice transplanted with Lin cells from
wild-type, Cd44/, Selplg/, or Selplg//
Cd44/ (DKO) donors that were transduced
with GFP control or shESL-1 vectors.
(A) Quantitative summary of E-selectin-binding
intensities in all eight groups. Error bars repre-
sent mean ± SEM. The inset shows expanded
E-selectin binding for the Selplg/ and DKO
groups. n = 6–18 mice per group. *p = 0.08
and **p < 0.0001 compared to the respective
GFP vector controls; #p < 0.0001 compared
to WT GFP vector; zp < 0.0001 compared to
WT or CD44 GFP vector groups; and xp <
0.0001 compared to WT or CD44 shESL-1
groups.
(B) Representative dot plots showing GFP
expression (upper quadrants) and E-selectin
binding in the control (top panels) or shESL
(middle panels) groups. Control binding in the
presence of EDTA in untransduced neutrophils
was used to set the quadrants. Histograms
(bottom panels) show overlays of E-selectin
binding to neutrophils from the GFP control
(light line) and shESL-1 (dark line) groups, as
well as control binding in the presence of
EDTA (solid gray) for each donor group.
(C) Rolling-flux fractions. The behavior of GFP+
leukocytes, transduced with either the GFP
control or the shESL-1 vector, was tracked in
real time with high-speed digital video micros-
copy between 150 and 210 min after TNF-a administration. The inset shows expanded rolling fractions for the Selplg/ and DKO groups. Error bars
represent mean ± SEM. Data derived from 60 chimeric mice and 448 venules. n = 6–11 mice per group; n = 48–60 venules per group. *p% 0.001 and
**p < 0.0001 compared to their respective GFP vector controls; #p < 0.0001 compared to wild-type (WT) GFP vector; zp < 0.0001 compared toWT and
Cd44/ transduced with GFP vector; and xp < 0.0001 compared to WT or CD44 transduced with shESL-1.It is important to note that the elevated rolling velocities
found in the shESL-1 groups (Figure 3) were independent
of these ‘‘skipping‘‘ kinetics because these velocity profiles
are obtained from leukocytes interacting with the endo-
thelium. These observations indicate distinct functions of
these glycoproteins during leukocyte tethering and rolling
in inflamed venules. Whereas PSGL-1 is critical for the
initial leukocyte capture and CD44 specializes in control-
ling leukocyte rolling velocities, ESL-1 cooperates with
PSGL-1 and CD44 in both activities and appears to play
a major role in stabilizing leukocytes into steady rolling.
Absence of PSGL-1, ESL-1, and CD44 Severely
Impairs Neutrophil Recruitment
Slow-rolling leukocytes integrate signals from chemo-
kines and E-selectin presented by the endothelium, result-
ing in their firm arrest on inflamed venules (Chesnutt et al.,
2006; Laudanna et al., 2002; Ley et al., 1998; Smith et al.,
2004). We therefore monitored the contributions of
PSGL-1, ESL-1, and CD44 in the arrest of leukocytes in
TNF-a-treated cremasteric venules by intravital micros-
copy. Absence of PSGL-1 or ESL-1 markedly reduced of
the number of arrested leukocytes, and the absence of
both PSGL-1 and ESL-1 further reduced leukocyte arrest480 Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc.to almost undetectable amounts (Figure 5A). However,
analyses of the arrest efficiencies (i.e., the fraction of roll-
ing leukocytes that undergo firm arrest) revealed a dra-
matic influence of ESL-1 alone (reduction by 63%) or
with CD44 (reduction by 86%) but no effect of PSGL-1
(Figure 5B). Arrest fractions and efficiencies in Sele/
mice (2.8% ± 0.8% and 0.20% ± 0.06%, respectively, in
n = 30 venules from four mice) were comparable to those
found in the absence of ESL-1 alone (p > 0.05 for both
parameters). These results underscore a major role for
ESL-1 and CD44 in the transition from rolling to firm arrest
and support the notion that PSGL-1, although critical for
initiation of rolling, does not significantly contribute to
the arrest of leukocytes that are already rolling.
To assess whether PSGL-1, ESL-1, and CD44 are the
physiological selectin ligandsmediating neutrophil extrav-
asation to inflammatory sites, we injected mice with thio-
glycollate, a chemical that induces a severe peritoneal
inflammation. The number of neutrophils in the peritoneal
exudate was evaluated 8 hr after injection, and the per-
centage of GFP+ control and shESL-1 neutrophils (defined
as Gr-1hi) relative to those of untransduced (GFPneg) cells
was determined in the blood and peritoneal exudate by
FACS analysis. Because the number of transduced
Immunity
Identification of Physiological E-Selection LigandsFigure 3. Analyses of Rolling Velocities in TNF-a-Inflamed Venules
(A) Mean rolling velocities. Data are derived from 1759 GFP+ leukocytes. Error bars represent mean ± SEM. *p% 0.002 and **p < 0.0001 compared to
their respectiveGFP vector controls; #p < 0.0001 compared toCd44/ and DKO transducedwith GFP vector; zp< 0.0001; and xp < 0.0001 compared
to all other shESL-1 groups.
(B) Cumulative histograms of rolling velocities. Shown are the velocity histograms for the groups transduced with GFP control (left panel) or shESL-1
vectors (right panel). Shown for comparison in the right panel is the histogram from wild-type leukocytes transduced with GFP control vector
(discontinuous pink line).leukocytes is variable among transplanted animals, we
determined the ratio of GFP+ Gr-1hi neutrophils in the
exudate versus blood to estimate the efficiency of extrav-
asation (see Figure S5 and Table S2 for details). PSGL-1-
deficient or shESL-1-transduced neutrophils showed
a significant but moderate reduction in their ability to
extravasate. However, the number of peritoneal Selplg/
Cd44/ neutrophils was strongly reduced (by 65%)
compared to the wild-type (Figure 5C). Remarkably, the
absence of all three glycoproteins dramatically impaired
neutrophil recruitment (>85%) to the peritoneum, to an
extent similar to that found in animals deficient in both
endothelial selectins (Bullard et al., 1996; Frenette et al.,
1996). These results indicate that PSGL-1, ESL-1, and
CD44 are specifically endowed with virtually all detectable
endothelial-selectin ligand activity and that no other
glycoproteins or glycolipids can compensate for their
deficiency.E-Selectin Signals into Rolling Leukocytes
through CD44
Previous studies have shown that the ligation of E-selectin
ligands can trigger the polarization of L-selectin and
PSGL-1 on human neutrophils in vitro (Green et al.,
2004; Simon et al., 2000). To determine whether this phe-
nomenon also takes place in vivo, we assessed in real time
L-selectin distribution on rolling leukocytes by using high-
speed fluorescence video microscopy (Figure S6 and
Movies S4 and S5). In these experiments, L-selectin distri-
bution on leukocytes was imaged in real time with a single
injection of low dose (0.02 mg/Kg) fluorescence-conju-
gated antibody to L-selectin in mice treated with TNF-a.
This dose of antibody resulted in only 15% occupancy
of surface receptors as determined by FACS analysis
(data not shown) but allowed clear real-time evaluation
of L-selectin distribution.We observed that a large fraction
of rolling wild-type leukocytes exhibited L-selectinFigure 4. ESL-1 Is Required for Steady
Rolling of Leukocytes
(A) ‘‘Skipping’’ rolling behavior of ESL-1-defi-
cient leukocytes. Tracings show near instanta-
neous velocity tracking of wild-type orCd44/
leukocytes transduced with GFP control or
shESL-1 vectors. Individual rolling velocities
were determined every 0.2 s from digital re-
cordings. Each line represents the fluctuation
in velocity of five individual rolling cells per
group over 5 s. Spikes in the shESL-1-trans-
duced groups (right histograms) reflect the be-
havior of cells that transiently detach from the
endothelium and retether shortly after.
(B) Percentages of GFP+ leukocytes displaying
a ‘‘skipping’’ behavior from the groups repre-
sented in (A). Data were obtained from 780 leu-
kocytes. n = 28–30 venules from four mice per
group. ***p < 0.0001.Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 481
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andCD44 in theAdhesion and Extravasa-
tion of Leukocytes
(A) The adherent fraction reflects the propor-
tion of firmly adherent GFP+ leukocytes out
of all circulating GFP+ leukocytes counted
over 1 min. Data were derived from 448
venules in 60 chimeric mice. n = 6–11 mice,
n = 48–60 venules per group.
(B) Arrest efficiencies reflect the proportion of
rolling GFP+ leukocytes that undergo firm ar-
rest. Data were derived from 354 venules
from 60mice. n = 6–11mice, n = 13–69 venules
per group.
(C) Neutrophil extravasation into inflammatory sites was determined in thioglycollate-induced peritonitis. Extravasated PMNs were estimated 8 hr
after intraperitoneal injection of thioglycollate in mice transplanted with bone-marrow cells transduced with the control or shESL-1 vector. The pro-
portions of transduced neutrophils (GFP+ Gr-1hi) in the circulation and in the peritoneum was determined by FACS analysis and used for calculating
the extravasation efficiencies (see Figure S5 and Table S2). Data from 54 mice, n = 5–9 mice per group. *p < 0.05 and **p < 0.001 compared to the
respective GFP vector controls; #p = 0.0076; zp < 0.0001 compared to wild-type or Cd44/ transduced with GFP vector; and xp < 0.0001 compared
to wild-type or Cd44/ transduced with shESL-1.polarization (Figure 6A). This fraction progressively in-
creased over time to reach a plateau of 60% polarized
leukocytes 200 min after TNF-a injection (Figure 6B).
Both L-selectin and PSGL-1 clusters colocalized on rolling
leukocytes (76/76 analyzed leukocytes from three experi-
ments; Figure S7). To assesswhether this phenomenon de-
pends on E-selectin, we evaluated L-selectin distribution in
Sele/ mice. We found that much fewer rolling leuko-
cytes (23.5% ± 1.5%) displayed such polarized distribu-
tion of L-selectin in Sele/ mice (Figure 6B), indicating
that ligation of E-selectin ligands in vivo induces the redis-
tribution of adhesion molecules on rolling leukocytes.
To determine which glycoprotein ligand mediates
E-selectin-dependent activation of leukocytes in vivo, we
analyzed L-selectin clustering on rolling leukocytes from
mice transplanted with BM cells from wild-type,
Cd44/, or Selplg/ mice or wild-type BM cells trans-
duced with the shESL-1 lentiviral vector (see Table S3
for venular hemodynamic parameters). We found that a
high proportion of rolling leukocytes deficient in PSGL-1
or ESL-1 exhibited L-selectin clustering (63% ± 4% for
Selplg/ and 71%± 5% for shESL-1; Figure 6C). In sharp
contrast, the number of rolling leukocytes with clustered
L-selectin was markedly reduced (20% ± 2%; Figure 6C),
to the amounts of Sele/ mice, when CD44 was absent.
These results indicate that CD44 is the signaling receptor
mediating E-selectin-dependent redistribution of L-selec-
tin on rolling leukocytes in vivo. To determine whether p38
MAPK signaling was involved in CD44-mediated L-selectin
redistribution, we treated wild-type mice with the inhibitor
SB203580 prior to intravital-microscopy observation. Inhi-
bition of p38 activation significantly reduced L-selectin
redistribution on rolling leukocytes (Figure 6D), suggesting
that this pathway is involved in downstream signals from
CD44. Furthermore, the engagement of CD44 on primary
neutrophils by Mab crosslinking strongly induced p38
phosphorylation (Figure 6E). p38 activation was specific
because it did not occur whenCd44/ PMNswere tested
in parallel (Figure 6E). CD44 crosslinking on neutrophils in-
duced strong PSGL-1 polarization, which was completely
inhibited by preincubation of PMNs with SB203580482 Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc.(Figure 6F). These experiments thus demonstrate that
the engagement of CD44 on neutrophils triggers p38-
mediated clustering of surface glycoproteins.
Because CD44 mediates steady slow rolling and
PSGL-1 does not play a major role once the leukocyte
has engaged into steady rolling, we hypothesized that
these two glycoproteins are differentially distributed on
slow-rolling leukocytes. To investigate this issue, we im-
aged the distribution of PSGL-1 and CD44 on leukocytes
in TNF-a-treated mice. For avoiding undesired binding of
the CD44 antibody to the endothelium, these experiments
were carried out in CD44-deficient mice reconstituted with
wild-type bone marrow. We found that PSGL-1 was clus-
tered in a manner similar to L-selectin on the majority of
slow-rolling leukocytes (Figure 6G). In contrast, on rolling
leukocytes displaying polarized PSGL-1, CD44 remained
evenly distributed on most rolling cells (88%) and in
some instances was more densely distributed in areas of
contact with the endothelium (Figure 6G). Thus, these
results suggest that the surface distributions of CD44
and PSGL-1 in slowly rolling leukocytes reflect their
distinct functions.
DISCUSSION
In these studies, we have identified virtually all endothelial-
selectin ligand activity mediating leukocyte recruitment to
inflammatory sites.Our results suggest thatPSGL-1, ESL-1,
and CD44 are specifically targeted by ligand-synthesizing
glycosyltransferases and that no other neutrophil glyco-
protein or glycolipid can compensate for their absence.
We show that these ligands closely collaborate with
each other to facilitate leukocyte recruitment. Moreover,
our results suggest a highly dynamic collaboration in
which, for instance, the engagement of E-selectin through
one ligand (e.g., CD44) can induce signals culminating in
the redistribution of another (e.g., PSGL-1) in actively
rolling leukocytes. Although each ESL exerts remarkably
distinct functions, ESL-1 appears to stand out as the
most powerful and versatile.
Immunity
Identification of Physiological E-Selection LigandsFigure 6. CD44 Mediates E-Selectin-Induced Clustering of L-Selectin on Rolling Leukocytes
(A) Imaging of L-selectin distribution on rolling leukocytes (see Movies S4 and S5) in a TNF-a-treated mouse. Top panels show fluorescence images
(Cy3 channel), and bottom panels show the fluorescence intensity plots of two rolling leukocytes with clustered L-selectin (shown in red). Real time
(s: ms) is displayed on the upper left. The arrow indicates the direction of flow. The scale bar represents 10 mm.
(B) L-selectin clustering is E-selectin dependent. The percentage of rolling leukocytes displaying clustered L-selectin in wild-type and Sele/mice is
shown, *p < 0.05.
(C) E-selectin-dependent L-selectin clustering on rolling leukocytes requires CD44-mediated signaling. L-selectin polarization was determined in a
total of 4320 rolling leukocytes from 17–30 venules (three to five mice) per group. Only GFP+ leukocytes were analyzed in the shESL-1 group.
**p < 0.0001 for Sele/ and Cd44/ compared to all other groups.
(D) L-selectin clustering in rolling leukocytes is p38 dependent. Wild-type mice were injected with vehicle or SB203580 before analysis of L-selectin
redistribution by intravital microscopy. Results are derived from the analysis of 954 rolling cells; n = 14–16 venules (three to four mice) per group.
*p < 0.0001.
(E) Cross-linking of CD44 activates p38. PMNs from wild-type or Cd44/mice were incubated with the control or CD44 antibodies and analyzed for
the presence of phospho-p38 by immunoblotting. Shown is a representative experiment of two.
(F) Crosslinking of CD44 induces p38-mediated clustering of PSGL-1. PMNs were treated or not treated with SB203580; CD44 was engaged by
antibody crosslinking; and surface PSGL-1 was stained. Cells were analyzed for PSGL-1 distribution (PSGL-1 in red and DAPI in blue; top panels).
Shown is the frequency of neutrophils with polarized PSGL-1 on the cell surface (bottom bar graph). Data from three independent experiments are
shown, *p < 0.001. The scale bar represents 10 mm.
(G) Differential distribution of PSGL-1 and CD44 on rolling leukocytes. TNF-a-treated mice were injected with APC-conjugated CD44 antibodies and
PE-conjugated PSGL-1 antibodies. Fluorescence images (CD44 in green; PSGL-1 in red; left panels) and fluorescence intensity plots (right panels)
show two leukocytes with CD44 evenly distributed or concentrated on the leukocyte-endothelium interface (arrowheads), whereas PSGL-1 is clus-
tered to the luminal side (red areas in right-bottom panel). The bottom panel shows blended images from fluorescence and brightfield channels to
allow the visualization of the leukocyte-endothelial interface. The arrow indicates the direction of flow. The scale bar represents 10 mm.Solid biochemical studies have implicated ESL-1 as a
ligand for E-selectin (Huang et al., 2000; Steegmaier
et al., 1995; Wild et al., 2001). However, the wide expres-
sion of the Glg1 gene in multiple tissues (Burrus et al.,
1992; Gonatas et al., 1989; Steegmaier et al., 1995), cellu-
lar compartments (Gonatas et al., 1998; Kohl et al., 2000;Steegmaier et al., 1997), and extracellular milieux (Olofs-
son et al., 1997) has puzzled researchers in this field for
more than a decade. Glg1/mice have a skeletal pheno-
type characterized by growth retardation, but no defect
in leukocyte rolling behavior was noted by intravital mi-
croscopy (B. Lee, K. Ley, and A. Beaudet, personalImmunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 483
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Mediated Leukocyte Tethering, Rolling,
and Activation
Free-flowing leukocytes tether on selectins ex-
pressed on the inflamed endothelium through
high-affinity interactions mostly mediated by
PSGL-1 and ESL-1, both of which are present
on microvilli. P-selectin interacts exclusively
with PSGL-1, whereas E-selectin can engage
both PSGL-1 and ESL-1. ESL-1, present on
the lateral aspects of microvilli, is critical for
stabilization and the transition to steady rolling
on E-selectin. Microvilli are likely to recede in
stably rolling leukocytes, thus exposing CD44
that controls rolling velocities together with
ESL-1. Engagement of leukocyte CD44, present
on the planar surface but excluded from microvilli, initiates signaling events that activate the p38 MAPK and result in L-selectin and PSGL-1 redis-
tribution in a major pole on rolling leukocytes. We speculate that the E-selectin-CD44-dependent clustering of PSGL-1 and L-selectin promote
secondary tethering of leukocytes with each other. Gradient bars at the bottom indicate the range of action of PSGL-1, ESL-1, and CD44 in this
sequence of events.communication). The present studies, however, with spe-
cific downregulation of Glg1 gene expression in hemato-
poietic cells, clearly demonstrate that ESL-1 is indeed
a major ESL on leukocytes. The possible difference be-
tween the knockdown and the genetic knockout may re-
sult from compensation mechanisms during development
in mice genetically deficient from the embryonic stage. It
is possible that such compensation mechanisms are not
operative when the expression of a gene is altered in the
adult. Knockdown by lentiviral delivery of shRNA in hema-
topoietic stem and progenitor cells presents several po-
tential advantages to study ESL-1. First, it circumvents
the possible influences of theGlg1 gene from nonhemato-
poietic expression because it can be targeted specifically
to postnatal bone marrow Lin cells. Second, the genera-
tion of chimeric animals by bone-marrow transplantation
provides the means to track specifically GFP+ leukocyte
progeny in the vasculature or in tissues. Third, the pres-
ence of both deficient (transduced) and sufficient (non-
transduced) leukocytes simultaneously in the same animal
gives rise to a competitive environment that is likely to be
more sensitive than classical genetic knockout within an
entire hematopoietic compartment. Finally, the incomplete
downregulation of gene expression at the cellular level
may have allowed themaintenance of normal homeostatic
cellular functions in transduced cells. Indeed, the residual
15% cellular expression of ESL-1 appears to be suffi-
cient for transduced stem cells to engraft, survive, and
proliferate normally in the bone marrow of recipient
mice. Thus, our results do not exclude other functions of
ESL-1, for instance in hematopoietic cell proliferation
and survival. It is noteworthy that the surface expression
of ESL-1 was negligible on the cell surface of shESL-1-
transduced cells where it appears dispensable for vital
cellular functions. Therefore, shRNA downregulation of
Glg1 gene expression has predominantly depleted sur-
face ESL-1 but maintained low levels of expression in
the Golgi apparatus.
Our results highlight the specialized contributions of
PSGL-1, ESL-1, andCD44 in various aspects of E-selectin-484 Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc.mediated leukocyte recruitment, including the initial cap-
ture (tethering), transition to steady rolling, slow rolling,
firm adhesion, and signaling (Figure 7). PSGL-1 mediates
the capture of free-flowing leukocytes to the endothelium
through its interaction with both P- and E-selectins. This
function is supported by fast association and dissociation
rates (Mehta et al., 1998) and its location on the very tip of
leukocyte microvilli (Moore et al., 1995). ESL-1 has also
been reported to be concentrated on microvilli but mostly
excluded from the very tip (Steegmaier et al., 1997), and
CD44 is exclusively distributed on the planar surface of
the leukocyte (von Andrian et al., 1995). The present
studies indicate that ESL-1 may act as a bridge between
PSGL-1 and CD44 in that it contributes to the initial
capture with PSGL-1 and it controls, with CD44, the veloc-
ity and arrest of rolling leukocytes on the endothelium.
Therefore, ESL-1 appears to be the most versatile ESL,
but its unique contribution to leukocyte recruitment
is arguably in the transition to steady slow rolling. In con-
trast to PSGL-1 and ESL-1, the contribution of CD44
becomes apparent only at the later stages of the leukocyte
recruitment cascade. It is tempting to speculate that
microvilli is likely to recede as the leukocyte integrates
activation signals, allowing CD44, buried in the planar
interface, to interact with E-selectin and support steady
slow rolling.
It is remarkable that CD44-mediated signals resulting
from its interaction with E-selectin can induce the redis-
tribution and clustering of adhesion molecules (e.g., L-
selectin and PSGL-1) expressed on the tip of microvilli.
Leukocyte polarization, unexpectedly, was observed in
the majority of slow-rolling leukocytes R190 min after
TNF-a administration, required E-selectin signals trans-
mitted exclusively by CD44, and involved p38. These
results are consistent with recent in vitro studies revealing
that the engagement of soluble E-selectin on human neu-
trophils could trigger capping of L-selectin and PSGL-1 in
a p38-dependent manner (Green et al., 2004). Why would
PSGL-1 and L-selectin redistribute on one major pole of
slow-rolling leukocytes? The redistribution of receptors
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these receptors no longer play important roles on micro-
villi of leukocytes engaged in slow rolling. It is likely that
clustered L-selectin and PSGL-1 provide an additional
platform for capturing circulating leukocytes and enhance
further leukocyte recruitment through leukocyte–leukocyte
interactions. A phenomenon of string formation down-
stream of rolling cells has been well documented in flow
chambers in vitro (Alon et al., 1996; Bargatze et al.,
1994). Although such strings have not been clearly dem-
onstrated in vivo, brightfield intravital microscopy analy-
ses have revealed that leukocyte–leukocyte interactions
contribute to leukocyte recruitment through the binding
of PSGL-1 to L-selectin (Sperandio et al., 2003). The indi-
vidual roles of slow rolling and firm leukocyte adhesion in
this activity have not been evaluated. Interestingly, we
have observed by using high-speed intravital digital video
microscopy that the vast majority (95%) of adherent
leukocytes migrating on TNF-a-inflamed venules exhibit
polarization of PSGL-1 and L-selectin at the trailing edge
(Chiang et al., 2007).
It is important to emphasize that the critical role of CD44
to signal clustering of L-selectin and PSGL-1 does not
exclude a role for other ESLs in cell signaling. Previous
reports have suggested that soluble E-selectin (Ruchaud-
Sparagano et al., 1998), crosslinking of neutrophil PSGL-
1 (Green et al., 2004), or the engagement of P-selectin to
PSGL-1 (Evangelista et al., 1999) may induce activation
of b2 integrins. However, intravital-microscopy studies
have indicated that PSGL-1 is not the ESL that cooperates
with the chemokine receptor CXCR2 to induce leukocyte
arrest in vivo (Smith et al., 2004). Although we show here
that CD44 can clearly signal the redistribution of other
adhesion molecules, it is not clear whether CD44 or
another ESL (e.g., ESL-1) mediates b2 integrin activation.
The present studies in fact suggest that ESL-1 may repre-
sent the leading candidate because the depletion of
surface ESL-1 appears to be sufficient to alter significantly
the in vivo arrest of wild-type leukocytes.
In summary, we have shown that virtually all endothelial-
selectin ligand activity is provided by three glycoproteins
on mouse neutrophils. PSGL-1, ESL-1, and CD44 exhibit
remarkably distinct, highly dynamic functions for optimiz-
ing leukocyte capture to the venular endothelium and re-
cruitment into inflamed tissues (Figure 7). Taken in the
context of recent literature, these data suggest that the in-
terplay of selectin ligands’ physical attributes, including
spatial cellular distribution, a unique structure allowing al-
losteric modulation of binding (Phan et al., 2006), and spe-
cific intracellular signaling, may dictate their tightly regu-
lated functions in the inflammatory response.
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6 male mice were purchased from Charles River
(Wilmington, MA). Sele/ mice were backcrossed into the C57BL/6
background (Frenette et al., 1996). Cd44/ animals were purchased
from the Jackson Laboratory (Bar Harbor, ME) (Protin et al., 1999).
Selplg/ mouse colony was derived from breeding pairs given byDr. Bruce Furie (Harvard Medical School, Boston, MA) (Yang et al.,
1999). Cd44//Selplg/ DKO mice were generated in our laboratory
(Katayama et al., 2005). All animals were housed at the Mount Sinai
School of Medicine barrier facility. Experimental procedures per-
formed on the animals were approved by the Animal Care and Use
Committee of Mount Sinai.
Design and Cloning of the shRNA Lentivirus System
The LentiLox 3.7 (pLL3.7) vector and the three packaging vectors
(pVSV-G, pRSV-REV, and pMDLg/pRRE) required for lentiviral pro-
duction have been described (Rubinson et al., 2003). The vector was
engineered by introduction of the mouse U6 promoter upstream of
a CMV-EGFP expression cassette to create a vector that simulta-
neously produces shRNAs and the GFP reporter gene. We selected
two shRNA sequences by using a computer software (http://www.
dharmacon.com), and they were ligated into HpaI and XhoI sites
downstream of the U6 promoter. These sequences derived from the
intraluminal domain of ESL-1 and were entirely specific to ESL-1 as
determined by a genome wide comparison. We verified the integrity
of the inserted oligonucleotides by sequencing. One of the vectors re-
sulted in greater reduction of ESL-1 protein as determined by western
blotting and was selected for our experiments (Figure S1). The oligonu-
cleotide sequence of this shESL-1 for the sense strand is as follows: 50-
TGT GTA GAG AAG CAC TAA CTT TCA AGA GAA GTT AGT GCT TCT
CTA CAC TTT TTT C-30 and as follows for the antisense strand: 50-TCG
AGA AAA AAG TGT AGA GAA GCA CTA ACT TCT CTT GAA AGT TAG
TGC TTC TCT ACA CA-30. In some experiments, a vector containing
a scrambled version of the shESL-1 sequence was used. The oligonu-
cleotide sequence of the scrambled shESL-1 for the sense strand is as
follows: 50-TGAACAGTTAGGAATCACGTT TCAAGAGAACGTGAT
TCC TAA CTG TTC TTT TTT C-30, and as follows for the antisense
strand: 50-TCG AGA AAA AAG AAC AGT TAG GAA TCA CGT TCT
CTT GAA ACG TGA TTC CTA ACT GTT CA-30. This sequence does
not target any known mRNAs in the mouse genome. Analyses of
mice transplanted with Linneg cells derived from Selplg/ mice and
transduced with the scrambled vector revealed a leukocyte behavior
identical to that found in the Selplg/ group transduced with the
GFP control vector in all parameters analyzed (Figure S8).
Generation of Lentivirus
Lentiviral particles were produced by cotransfection of the lentiviral
and three packaging vectors into 293T cells. Viral-containing superna-
tants were collected after 36 hr and concentrated by ultracentrifuga-
tion for 90 min at 25,000 rpm in a Beckman SW28 rotor. Viral pellets
were resuspended in cold PBS and stored at 80C until use. Titers
were determined by infection of 293T cells with serial dilutions of con-
centrated lentiviral particles in the presence of 8 mg/mL polybrene
(Fluka, Steimheim, Switzerland). Titers ranged from 2 to 63 108 infec-
tious particles per mL. Percentages of GFP+-infected cells were mea-
sured by flow cytometry 48 hr after infection, and absolute numbers
were calculated.
Hematopoietic Stem Cell Infection and Bone-Marrow
Transplant
We harvested donor BM cells from the appropriate genotype (wild-
type, Cd44/, Selplg/, or Cd44//Selplg/ DKO) by flushing
both tibiae and femora into PBS containing 0.5% FBS and 2 mM
EDTA (PEB buffer). Low-density mononuclear cells (MNC) were col-
lected after centrifugation at 250 g over a 65% percoll solution and
washed in PEB buffer. Contaminating erythrocytes were lysed in
a 0.8% NH4Cl solution. MNCs were incubated for 20 min at 4
C with
a cocktail of lineage antibodies comprising rat anti-mouse Gr-1,
CD45R/B220, and TER119 (from BD PharMingen, San Diego, CA)
and CD33 (Southern Biotech, Birmingham, AL) and CD11b (M1/70
clone, purified from hybridoma supernatants). Cells were washed
and incubated for 30 min at 4Cwith sheep anti-rat Dynabeads (Dynal,
Olso, Norway) in accordance with the manufacturer’s instructions.
Lin cells were separated with a magnet, washed, and counted. CellsImmunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 485
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Cell Technologies, Vancouver, BC, Canada), 20 mM HEPES, 2 mM
L-glutamine, 50 mM 2-Mercaptoethanol, 20 ng/mL Flt-3, 100 ng/mL
mouse SCF, 10 ng/mL IL-11 (all cytokines from R&D Systems, Minne-
apolis, MN), 8 mg/mL polybrene, and 75 mg/ml verapamil (MP Biomed-
icals, Solon, OH). Cells were mixed with viral concentrates (multiplicity
of infection: 10–20) and centrifuged for 90 min at 2500 rpm at room
temperature (RT), after which they were maintained in culture at
37C for 3–12 hr before transplant. Recipient wild-type C57BL/6
mice were lethally irradiated (1200 cGy, split doses 3 hr apart) prior
to receiving 2 to 43 105 transduced Lin cells by retroorbital injection.
Engraftment of recipient animals was assessed at least 3 weeks after
transplantation by retroorbital bleeding and analysis of GFP+ leuko-
cytes by flow cytometry.
Cell Line and E-Selectin-IgM Chimeric Protein
The 32D mouse myeloid progenitor and bEnd.3 brain endothelial cell
lines (ATCC, Manassas, VA) were cultured as previously described
(Katayama et al., 2005). Parental 32D cells were spin infected with
either GFP control or shESL-vectors, expanded in culture, and sorted
with a FACS Vantage SE cell sorter (Becton Dickinson) on the basis of
GFP expression. The E-selectin-IgM chimera was produced and used
as described in (Katayama et al., 2005). 293T cells were cultured in
DMEM media (Cellgro, Herndon, VA) containing 5% FBS (Hyclone,
Logan, UT).
Flow Cytometry and E-Selectin-Binding Assay
Primary blood leukocytes were stained by incubation with 10 mg/mL of
biotin-labeled antibodies against CD44 (clone IM7, BD Biosciences),
PSGL-1 (clone 4RA10), or biotinylated control IgG, and this was
followed by incubation with Cy5-conjugated streptavidin (Jackson
ImmunoResearch Laboratories). Fluid-phase binding of the E-selectin-
IgM chimera to blood leukocytes was performed as described previ-
ously (Katayama et al., 2005). Neutrophils were gated on the basis of
low forward-scatter and high side-scatter. Samples were acquired
with a FACSCalibur flow cytometer and analyzed with the CellQuest
software (Becton Dickinson).
Thioglycollate-Induced Peritonitis
To assess neutrophil recruitment efficiency, we generated cohorts of
chimeric mice by transplantation with BM cells of all four genotypes
(wild-type, Cd44/, Selplg/, or Cd44//Selplg/ DKO) trans-
duced with control or shESL-1 vectors. At least 4 weeks after trans-
plantation, mice were injected intraperitoneally with 1 ml of thioglycol-
late as previously described (Katayama et al., 2005). After 8 hr, venous
blood and peritoneal exudates were collected and aliquots stained
with APC-conjugated Gr-1 antibody (Pharmingen, BD Biosciences).
Samples were analyzed by flow cytometry as indicated above. For
estimating the efficiency of extravasation into the peritoneum, the ratio
of GFP+ neutrophils between the blood and the exudates was deter-
mined. The absolute number of neutrophil recruitment in the four differ-
ent genotypes was determined in mice that were transplanted with
uninfected BM cells from all four genotypes. The ratios of blood versus
peritoneum GFP+ neutrophils were then applied to the total number of
neutrophils in each group for estimation of the absolute recruitment
efficiencies (further details in Figure S5 and Table S2).
Intravital Microscopy
Mice were injected intrascrotally with 0.5 mg recombinant mouse TNF-
a (R&D Systems) and anesthetized with 2% achloralose and 10%
urethane (Sigma-Aldrich, St. Louis, MO) in PBS and tracheotomized
with PE-160 polyethylene tubing (Becton Dickinson). The cremaster
muscle was carefully exteriorized, opened with cautery, and secured
across a Plexiglas platform with sutures. Exposed tissues were contin-
uously superfused with endotoxin-free bicarbonate-buffered saline,
equilibrated with 95% N2 and 5% CO2, and warmed to 37
C. Immedi-
ately before recording, 1 mg of an Alexa-Fluor-647-conjugated rat IgG
antibody (prepared with the Alexa-Fluor-647-antibody labeling kit from486 Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc.Molecular Probes, Eugene, OR) was injected for delineation of the
vasculature. All movies were acquired with an Olympus BX61WI work-
station mounted on a motorized X,Y stage (Applied Scientific Instru-
mentation, Eugene, OR), which allows precise computer-controlled
lateral movement between XY positions and a Z focusing drive so
that the focal plane can be rapidly changed. A LUMPlanFI 603 NA
0.90N water-immersion objective was used for all recordings (Olym-
pus, Melville, NY). The microscope is equipped with a Lambda DG-4
high-speed wavelength switcher based on dual scanning galvanome-
ters (Sutter Instrument, Novato, CA) from a 175-Watt xenon light
source with excitation filters (360, 480, and 590 nm) matched to a
triple-band filter for DAPI, FITC, and Cy3 and individual filter sets for
DAPI, FITC, Cy3, Texas Red, and Cy5 (Chroma, Brattleboro, VT) in
the body of the microscope. Transmitted bright-field light was deliv-
ered through a shutter (Uniblitz VS25, Vincent Associates, Rochester,
NY) allowing the acquisition of both bright-field and fluorescence
images without interruption through computer control. Images were
collected with a SensiCam camera (9.9 mm2 pixel, 640 3 480 pixel
format; Cooke, Auburn Hills, MI) mounted on a Videoscope image
intensifer (Sterling, VA). The SlideBook software (Intelligent Imaging
Innovations, Denver, CO), run on aDell Precision 650 computer system
(Dell, Inc, Round Rock, TX) with dual Xeon 3.06GHz microprocessors
and 3.0 GB of RAM, coordinated image acquisition and allowed offline
data analysis.
Six to ten venules per mouse were analyzed 150 to 210 min after
TNF-a treatment by acquisition of fluorescence (FITC channel for
GFP) and bright-field images with 23 2 binning for 2min. For obtaining
centerline blood velocities, a 7–10 s movie was acquired for each
venule, at 40 frameper second (fps) with the FITCchannel, 43 4 binning,
to allow detection of free-flowing cells.
For analyses of L-selectin distribution on the surface of rolling cells,
we prepared mice for intravital microscopy (IVM) as indicated above
except that they were injected i.v. immediately before recording with
0.02 mg/Kg of PE-conjugated L-selectin antibody (clone MEL-14,
BD Biosciences) as well as the Alexa-Fluor-647-conjugated rat IgG
antibody. Movies were recorded for 1–2 min by acquisition of either
fluorescence and bright-field images or fluorescence only (FITC and
Cy3 channels) at 5 fps, 2 3 2 binning. Centerline velocities were esti-
mated as above except that the Cy3 fluorescence channel was used
to detect free-flowing cells. In some experiments, 0.02 mg/Kg PE-
conjugated PSGL-1 and APC-conjugated CD44 antibodies (clones
2PH1 and IM7, respectively, BD Biosciences) were injected and
analyzed as indicated above.
Analysis of IVM Experiments
Wall shear rates (g) were calculated on the basis of Poiseuille’s Law for
a Newtonian fluid. g = 8 (Vmean/Dv), where Dv is the diameter of the ve-
nule and Vmean is estimated form the centerline RBC velocities (VRBC),
with the empirical correlation Vmean = VRBC/1.6. We measured VRBC for
each venule with high-speed (40 fps) recordings by dividing the dis-
tance traveled by the fastest free-flowing cells per frame by 0.026 s
(40 fps = 26ms/frame). Each rolling leukocyte passing through the field
of view (150 mm long) was counted, andwe calculated leukocyte rolling
flux by dividing leukocyte rolling flux by the total leukocyte flux, which
was estimated as (GFP-WBC) 3 Vmean/p/(d/2)
2, where GFP-WBC is
the number of GFP+WBCper ml of blood and d is the venular diameter.
An automated cell counter was used to determine absolute WBC
counts from blood samples obtained from retro-orbital bleeding at
the end of the experiment, and the percentage of GFP+ leukocytes
was determined by flow cytometry. Leukocyte rolling velocities were
measured for each GFP+ cell by the measurement of the distance
traveled during 2 s. Leukocytes were considered ‘‘arrested’’ if they
remained static forR30 s.
For analysis of L-selectin clustering, movies were converted into 2D
time-lapse intensity plots with the SlideBook software. Rolling cells
that presented intensity levels of at least 2-fold over the rest of the
cell body in a discrete region (5%–30% of the cell surface) were con-
sidered ‘‘polarized’’ (see Figure S6).
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A recombinant ESL-1 protein (ESL-1myc) consisting of the extracellu-
lar part of ESL-1 (Steegmaier et al., 1995) and a C-terminal Myc-tag
was obtained as described before (Wild et al., 2001) and was used
to immunize a rabbit giving rise to anti-ESL-1 serum VE12. For immu-
nostaining, blood samples frommice transplanted with GFP control or
shESL-1-transduced Lin cells were depleted of RBCs by lysis in 0.8%
NH4Cl buffer, and the remaining leukocytes cytospun onto slides. Cells
were fixed with 4% paraformaldehyde, washed with PEB buffer, and
blocked with 1:500 dilution of goat serum in PEB buffer. After washing,
cells were incubated with PBS containing 0.1% Triton X-100 for 15min
and washed again before incubation with a 1:1000 dilution of an anti-
ESL-1 for 1 hr at RT. Cells were washed again and incubated with
a Cy5-conjugated rabbit antibody for 1 hr at RT. After extensive wash-
ing, samples were mounted with Vectashield containing DAPI (Vector
Laboratories, Burlingame, CA).
For the detection of PSGL-1 redistribution on neutrophils, bone-
marrow PMNs were purified on a discontinuous Percoll gradient
(65%). PMNs (106) were pretreated with 10 mM SB203580 for 45 min
at 37C and then incubated with 1 mg of control rat IgG or anti-CD44
(clone IM7) for 20 min at 4C. PMNs were washed, incubated with
1 mg anti-rat IgG antibody for 10 min at 37C, and then stained at
4C with 5 mg/mL of a PE-conjugated PSGL-1 antibody (Pharmingen,
BD Biosciences). After washing, cells were fixed in 2% paraformalde-
hyde and cytospun onto slides for fluorescence-microscopy analysis.
Western Blotting
Cells were biotinylated by incubation with 0.5 mg/mL of EZ-Link-sulfo-
NHS-LC-biotin (Pierce) for 30 min at 4C. After washing with PEB
buffer, cells were lysed in a buffer containing 10 mM Tris-HCl
(pH 7.5), 1% Triton X-100, 150 mM NaCl, a protease inhibitor cocktail
(Sigma), and 1mMPMSF. Lysates were depleted of cell debris by cen-
trifugation at 16,000 g for 15 min at 4C. An aliquot of lysates was kept
for estimation of total ESL-1. Lysates were then incubated overnight
with streptavidin-conjugated agarose (Sigma) at 4C, and unbound
proteins removed by extensive washing of the beads in lysis buffer.
Beads and total lysates were boiled for 4 min at 100C in the presence
of sample loading buffer containing 2% SDS and 10 mM DTT, and
proteins resolved in a 7% SDS-PAGE gel. Proteins were transferred
onto PVDF membranes (Millipore, Bedford, MA) and then blotted
with the anti-ESL-1 serum (1:1000 dilution). Bands were detected
with the ECL method (West Dura Extended Duration, Pierce). Because
the levels of GFP protein may affect total protein estimations in trans-
duced versus untransduced groups, extracts from the same cell
counts rather than protein content were loaded per lane.
For detection of phospho-p38, purified BM PMNs from wild-type or
Cd44/ mice were incubated with control or CD44 antibodies (clone
IM7) as indicated above, incubated in lysis buffer (50 mM Tris-HCl
[pH 7.5], 150 mM NaCl, 1% NP-40, 2 mM Na3VO4, 1 mM EDTA,
1 mM 4-(2-aminoethyl)- benzene sulfonylfluoride, 10 mM NaF, 5 mM
NaPPi, and 10 mM b-glycerophosphate) containing protease inhibi-
tors. Proteins from 2 3 105 cells were resolved by SDS-PAGE on
a 10% polyacrylamide gel. Gels were blotted onto PVDF membranes
and incubated with a phospho-p38 antibody (Cell Signaling Technol-
ogy; Danvers, MA) and then a peroxidase-conjugated rabbit antibody.
Bands were detected with the ECL method (Pierce).
Quantitative Real-Time RT-PCR
Total RNA was extracted from cells with the RNeasy mini kit (Qiagen).
Potential contaminating DNA was removed with the RNase-Free
DNase Set (Qiagen). Total RNA (1 mg) was reverse transcribed with
first-strand cDNA synthesis with random primers (Promega, Madison,
WI). Quantitative real-time RT-PCR was performed as previously
described (Katayama et al., 2006). The specific primers used to amplify
cDNA fragments corresponding to ESL-1 were as follows: 50-CAAGAT
GAC GGC CAT CAT TTT CA-30 (forward) and 50-TTC CCC AAG ACG
AAT GCT GC-30 (reverse), and the primers corresponding to the
housekeeping gene GAPDH were as follows: 50-TTG GCA TTG TGGAAG GGC TCA T-30 (forward) and 50-GAT GAC CTT GCC CAC AGC
CTT-30 (reverse). The PCR conditions were 95C for 2 min; 40 cycles
of 95C for 15 s, 55C for 15 s, and 72C for 30 s; and 1 cycle of
95C for 15 s, 60C for 15 s, and 95C for 15 s. All experiments were
done in triplicate and normalized to GAPDH.
Statistical Analyses
Data are presented as mean ± SEM. Different genotypes of the same
group (GFP vector or shESL-1) were analyzed by one-way ANOVAwith
Bonferroni/Dunn post-hoc test for multiple group comparisons with
the StatView software. p values < 0.0083 (5% risk level) were consid-
ered statistically significant for four-group comparisons, and p values
< 0.005 (5% risk level) were considered statistically significant for five-
group comparisons (Figure 6). Within each graph, groups of the same
genotype but different lentiviral transduction were compared with two-
tailed Student’s t test, with significance set at p < 0.05 (5% risk level).
Supplemental Data
Eight figures, three tables, and fivemovies are available at http://www.
immunity.com/cgi/content/full/26/4/477/DC1/.
ACKNOWLEDGMENTS
We thank B. Furie for providing the founders of our Selplg/ mouse
colony. We also thank S. Dahan for advice on the p38 studies and
A. Prats for excellent artistic input (Figure 7). This study was supported
by the National Institutes of Health R01 grants DK56638 and HL69438
to P.S.F. and a grant from the Charles Revson Foundation to
A.H. P.S.F. is an Established Investigator of the American Heart
Association.
Received: October 5, 2006
Revised: February 5, 2007
Accepted: March 5, 2007
Published online: April 19, 2007
REFERENCES
Alon, R., Feizi, T., Yuen, C.T., Fuhlbrigge, R.C., and Springer, T.A.
(1995). Glycolipid ligands for selectins support leukocyte tethering
and rolling under physiologic flow conditions. J. Immunol. 154,
5356–5366.
Alon, R., Fuhlbrigge, R.C., Finger, E.B., and Springer, T.A. (1996). Inter-
actions through L-selectin between leukocytes and adherent leuko-
cytes nucleate rolling adhesions on selectins and VCAM-1 in shear
flow. J. Cell Biol. 135, 849–865.
Bargatze, R.F., Kurk, S., Butcher, E.C., and Jutila, M.A. (1994). Neutro-
phils roll on adherent neutrophils bound to cytokine-induced endothe-
lial cells via L-selectin on the rolling cells. J. Exp.Med. 180, 1785–1792.
Bullard, D.C., Kunkel, E.J., Kubo, H., Hicks, M.J., Lorenzo, I., Doyle,
N.A., Doerschuk, C.M., Ley, K., and Beaudet, A.L. (1996). Infectious
susceptibility and severe deficiency of leukocyte rolling and recruit-
ment in E-selectin and P-selectin double mutant mice. J. Exp. Med.
183, 2329–2336.
Burrus, L.W., Zuber, M.E., Lueddecke, B.A., and Olwin, B.B. (1992).
Identification of a cysteine-rich receptor for fibroblast growth factors.
Mol. Cell. Biol. 12, 5600–5609.
Chesnutt, B.C., Smith, D.F., Raffler, N.A., Smith, M.L., White, E.J., and
Ley, K. (2006). Induction of LFA-1-dependent neutrophil rolling on
ICAM-1 by engagement of E-selectin. Microcirculation 13, 99–109.
Chiang, E.Y., Hidalgo, A., Chang, J., and Frenette, P.S. (2007). Imaging
receptor microdomains on leukocyte subsets in live mice. Nat.
Methods 4, 219–222.
Dimitroff, C.J., Lee, J.Y., Rafii, S., Fuhlbrigge, R.C., and Sackstein, R.
(2001). CD44 is a major E-selectin ligand on human hematopoietic
progenitor cells. J. Cell Biol. 153, 1277–1286.Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 487
Immunity
Identification of Physiological E-Selection LigandsEvangelista, V., Manarini, S., Sideri, R., Rotondo, S., Martelli, N.,
Piccoli, A., Totani, L., Piccardoni, P., Vestweber, D., de Gaetano, G.,
and Cerletti, C. (1999). Platelet/polymorphonuclear leukocyte interac-
tion: P-selectin triggers protein-tyrosine phosphorylation-dependent
CD11b/CD18 adhesion: Role of PSGL-1 as a signaling molecule.
Blood 93, 876–885.
Frenette, P.S., Mayadas, T.N., Rayburn, H., Hynes, R.O., and Wagner,
D.D. (1996). Susceptibility to infection and altered hematopoiesis in
mice deficient in both P-and E-selectins. Cell 84, 563–574.
Fuhlbrigge, R.C., King, S.L., Sackstein, R., and Kupper, T.S. (2006).
CD43 is a ligand for E-selectin on CLA+ human T cells. Blood 107,
1421–1426.
Gonatas, J.O., Chen, Y.J., Stieber, A., Mourelatos, Z., and Gonatas,
N.K. (1998). Truncations of the C-terminal cytoplasmic domain of
MG160, a medial Golgi sialoglycoprotein, result in its partial transport
to the plasma membrane and filopodia. J. Cell Sci. 111, 249–260.
Gonatas, J.O., Mezitis, S.G., Stieber, A., Fleischer, B., and Gonatas,
N.K. (1989). MG-160. A novel sialoglycoprotein of the medial cisternae
of the Golgi apparatus. J. Biol. Chem. 264, 646–653.
Green, C.E., Pearson, D.N., Camphausen, R.T., Staunton, D.E., and
Simon, S.I. (2004). Shear-dependent capping of L-selectin and P-
selectin glycoprotein ligand 1 by E-selectin signals activation of high-
avidity beta2-integrin on neutrophils. J. Immunol. 172, 7780–7790.
Hirata, T., Merrill-Skoloff, G., Aab, M., Yang, J., Furie, B.C., and Furie,
B. (2000). P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological
ligand for E-selectin in mediating T helper 1 lymphocyte migration.
J. Exp. Med. 192, 1669–1676.
Huang, M.C., Zollner, O., Moll, T., Maly, P., Thall, A.D., Lowe, J.B., and
Vestweber, D. (2000). P-selectin glycoprotein ligand-1 and E-selectin
ligand-1 are differentially modified by fucosyltransferases Fuc-TIV
and Fuc-TVII in mouse neutrophils. J. Biol. Chem. 275, 31353–31360.
Jones, W.M., Watts, G.M., Robinson, M.K., Vestweber, D., and Jutila,
M.A. (1997). Comparison of E-selectin-binding glycoprotein ligands on
human lymphocytes, neutrophils, and bovine gamma delta T cells.
J. Immunol. 159, 3574–3583.
Jung, U., Norman, K.E., Scharffetter-Kochanek, K., Beaudet, A.L., and
Ley, K. (1998). Transit time of leukocytes rolling through venules
controls cytokine-induced inflammatory cell recruitment in vivo.
J. Clin. Invest. 102, 1526–1533.
Katayama, Y., Battista, M., Kao, W.M., Hidalgo, A., Peired, A.J.,
Thomas, S.A., and Frenette, P.S. (2006). Signals from the sympathetic
nervous system regulate hematopoietic stem cell egress from bone
marrow. Cell 124, 407–421.
Katayama, Y., Hidalgo, A., Chang, J., Peired, A., and Frenette, P.S.
(2005). CD44 is a physiological E-selectin ligand on neutrophils. J.
Exp. Med. 201, 1183–1189.
Kohl, R., Antoine, M., Olwin, B.B., Dickson, C., and Kiefer, P. (2000).
Cysteine-rich fibroblast growth factor receptor alters secretion and
intracellular routing of fibroblast growth factor 3. J. Biol. Chem. 275,
15741–15748.
Kotovuori, P., Tontti, E., Pigott, R., Shepherd, M., Kiso, M., Hasegawa,
A., Renkonen, R., Nortamo, P., Altieri, D.C., and Gahmberg, C.G.
(1993). The vascular E-selectin binds to the leukocyte integrins
CD11/CD18. Glycobiology 3, 131–136.
Kunkel, E.J., and Ley, K. (1996). Distinct phenotype of E-selectin-defi-
cient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ.
Res. 79, 1196–1204.
Labow, M.A., Norton, C.R., Rumberger, J.M., Lombard-Gillooly, K.M.,
Shuster, D.J., Hubbard, J., Bertko, R., Knaack, P.A., Terry, R.W.,
Harbison, M.L., et al. (1994). Characterization of E-selectin-deficient
mice: Demonstration of overlapping function of the endothelial selec-
tins. Immunity 1, 709–720.488 Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc.Laudanna, C., Kim, J.Y., Constantin, G., and Butcher, E. (2002).
Rapid leukocyte integrin activation by chemokines. Immunol. Rev.
186, 37–46.
Ley, K. (2003). The role of selectins in inflammation and disease.
Trends Mol. Med. 9, 263–268.
Ley, K., Allietta, M., Bullard, D.C., and Morgan, S. (1998). Importance
of E-selectin for firm leukocyte adhesion in vivo. Circ. Res. 83,
287–294.
Lo, S.K., Lee, S., Ramos, R.A., Lobb, R., Rosa, M., Chi-Rosso, G., and
Wright, S.D. (1991). Endothelial-leukocyte adhesion molecule 1 stimu-
lates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18,
Mac-1, alpha m beta 2) on human neutrophils. J. Exp. Med. 173,
1493–1500.
Matsumoto, M., Atarashi, K., Umemoto, E., Furukawa, Y., Shigeta, A.,
Miyasaka, M., and Hirata, T. (2005). CD43 functions as a ligand for
E-Selectin on activated T cells. J. Immunol. 175, 8042–8050.
McEver, R.P. (2002). Selectins: Lectins that initiate cell adhesion under
flow. Curr. Opin. Cell Biol. 14, 581–586.
Mehta, P., Cummings, R.D., and McEver, R.P. (1998). Affinity and
kinetic analysis of P-selectin binding to P-selectin glycoprotein
ligand-1. J. Biol. Chem. 273, 32506–32513.
Montoya, M.C., Holtmann, K., Snapp, K.R., Borges, E., Sanchez-
Madrid, F., Luscinskas, F.W., Kansas, G., Vestweber, D., and
de Landazuri, M.O. (1999). Memory B lymphocytes from secondary
lymphoid organs interact with E-selectin through a novel glycoprotein
ligand. J. Clin. Invest. 103, 1317–1327.
Moore, K.L., Eaton, S.F., Lyons, D.E., Lichenstein, H.S., Cummings,
R.D., and McEver, R.P. (1994). The P-selectin glycoprotein ligand
from human neutrophils displays sialylated, fucosylated, O-linked
poly-N-acetyllactosamine. J. Biol. Chem. 269, 23318–23327.
Moore, K.L., Patel, K.D., Bruehl, R.E., Li, F., Johnson, D.A.,
Lichenstein, H.S., Cummings, R.D., Bainton, D.F., and McEver, R.P.
(1995). P-selectin glycoprotein ligand-1 mediates rolling of human
neutrophils on P-selectin. J. Cell Biol. 128, 661–671.
Olofsson, A., Hellman, U., Ten Dijke, P., Grimsby, S., Ichijo, H., Moren,
A., Miyazono, K., and Heldin, C.H. (1997). Latent transforming growth
factor-beta complex in Chinese hamster ovary cells contains the
multifunctional cysteine-rich fibroblast growth factor receptor, also
termed E-selectin-ligand or MG-160. Biochem. J. 324, 427–434.
Phan, U.T., Waldron, T.T., and Springer, T.A. (2006). Remodeling of
the lectin-EGF-like domain interface in P- and L-selectin increases
adhesiveness and shear resistance under hydrodynamic force. Nat.
Immunol. 7, 883–889.
Picker, L.J., Warnock, R.A., Burns, A.R., Doerschuk, C.M., Berg, E.L.,
and Butcher, E.C. (1991). The neutrophil selectin LECAM-1 presents
carbohydrate ligands to the vascular selectins ELAM-1 and GMP-
140. Cell 66, 921–933.
Protin, U., Schweighoffer, T., Jochum, W., and Hilberg, F. (1999).
CD44-deficientmice develop normally with changes in subpopulations
and recirculation of lymphocyte subsets. J. Immunol. 163, 4917–4923.
Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., Sievers, C., Yang, L.,
Kopinja, J., Rooney, D.L., Ihrig, M.M., McManus, M.T., Gertler, F.B.,
et al. (2003). A lentivirus-based system to functionally silence genes
in primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat. Genet. 33, 401–406.
Ruchaud-Sparagano, M.H., Drost, E.M., Donnelly, S.C., Bird, M.I.,
Haslett, C., and Dransfield, I. (1998). Potential pro-inflammatory
effects of soluble E-selectin upon neutrophil function. Eur. J. Immunol.
28, 80–89.
Simon, S.I., Hu, Y., Vestweber, D., and Smith, C.W. (2000). Neutrophil
tethering on E-selectin activates beta 2 integrin binding to ICAM-1
through a mitogen-activated protein kinase signal transduction path-
way. J. Immunol. 164, 4348–4358.
Immunity
Identification of Physiological E-Selection LigandsSmith, M.L., Olson, T.S., and Ley, K. (2004). CXCR2- and E-selectin-
induced neutrophil arrest during inflammation in vivo. J. Exp. Med.
200, 935–939.
Sperandio, M., Smith, M.L., Forlow, S.B., Olson, T.S., Xia, L., McEver,
R.P., and Ley, K. (2003). P-selectin glycoprotein ligand-1 mediates
L-selectin-dependent leukocyte rolling in venules. J. Exp. Med. 197,
1355–1363.
Steegmaier, M., Borges, E., Berger, J., Schwarz, H., and Vestweber, D.
(1997). The E-selectin-ligand ESL-1 is located in the Golgi as well as on
microvilli on the cell surface. J. Cell Sci. 110, 687–694.
Steegmaier, M., Levinovitz, A., Isenmann, S., Borges, E., Lenter, M.,
Kocher, H.P., Kleuser, B., and Vestweber, D. (1995). The E-selectin-
ligand ESL-1 is a variant of a receptor for fibroblast growth factor.
Nature 373, 615–620.
Vestweber, D., and Blanks, J.E. (1999). Mechanisms that regulate
the function of the selectins and their ligands. Physiol. Rev. 79,
181–213.
von Andrian, U.H., Hasslen, S.R., Nelson, R.D., Erlandsen, S.L., and
Butcher, E.C. (1995). A central role for microvillous receptor presenta-
tion in leukocyte adhesion under flow. Cell 82, 989–999.Wild, M.K., Huang, M.C., Schulze-Horsel, U., van der Merwe, P.A., and
Vestweber, D. (2001). Affinity, kinetics, and thermodynamics of
E-selectin binding to E-selectin ligand-1. J. Biol. Chem. 276, 31602–
31612.
Xia, L., Sperandio, M., Yago, T., McDaniel, J.M., Cummings, R.D.,
Pearson-White, S., Ley, K., and McEver, R.P. (2002). P-selectin
glycoprotein ligand-1-deficient mice have impaired leukocyte
tethering to E-selectin under flow. J. Clin. Invest. 109, 939–
950.
Yang, J., Hirata, T., Croce, K., Merrill-Skoloff, G., Tchernychev, B.,
Williams, E., Flaumenhaft, R., Furie, B.C., and Furie, B. (1999).
Targeted gene disruption demonstrates that P-selectin glycoprotein
ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-
selectin-mediated neutrophil rolling and migration. J. Exp. Med. 190,
1769–1782.
Zollner, O., Lenter, M.C., Blanks, J.E., Borges, E., Steegmaier, M.,
Zerwes, H.G., and Vestweber, D. (1997). L-selectin from human, but
not from mouse neutrophils binds directly to E-selectin. J. Cell Biol.
136, 707–716.Immunity 26, 477–489, April 2007 ª2007 Elsevier Inc. 489
